We encourage prospective D/P's (donor/participants) to become involved in current and future studies. If a study listed does not apply to your particular situation we still invite you to register so that we may include you in our database and contact you for future studies.
We are looking for D/P's in the following categories:
| ID # | Required D/P's | Enrolled D/P's | Remaining D/P's | Inclusion Criteria |
|---|---|---|---|---|
| 400337 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors |
| 400326 | 5 | 0 | 5 | Pre-Selected samples from HIV-positive Patients on Medication |
| 400173 | 1 | 0 | 1 | Pre-Selected High-Risk samples from Adult Donors (Additional samples from Donor ID# 128764) |
| 400074 | 250 | 0 | 250 | Serum Samples from Apparently Healthy Pediatric Donors_MassSpec Ref Range Project RD006866 |
| 400054 | 200 | 0 | 200 | Prospective Serum Samples Collection from HBV High-Risk Donors |
| 399920 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors |
| 399432 | 7 | 0 | 7 | Pre-selected HCV Positive Samples with Genotype Information from Inventory |
| 399409 | 10 | 0 | 10 | Pre-Selected Chlamydia trachomatis and/or Neisseria gonorrhoeae Positive Urine Samples from Inventory |
| 399335 | 132 | 0 | 132 | Prospective Serum Sample Collection from Healthy Pediatric Donors |
| 399298 | 10000 | 0 | 10000 | HxV and/or CBC Initiative |
| 399009 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors |
| 398814 | 30 | 0 | 30 | Pre-Selected Mycoplasma Genitalium Negative Urine Samples from Inventory |
| 398294 | 8 | 0 | 8 | HIV-1 Positive Stability Study |
| 398124 | 20 | 0 | 20 | Prospective Oropharyngeal, Vaginal and Rectal Swab from Donors with Previous CT/NG Positive Results |
| 398121 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors |
| 398076 | 6 | 0 | 6 | Vaginal Swabs Samples from CT Positive Donors (After screening on JR398074_4th Week) |
| 398074 | 60 | 0 | 60 | Vaginal Swab Samples from CT/NG Suspected Donors (Screening Collection_4th Week) |
| 398071 | 6 | 0 | 6 | Vaginal Swabs Samples from CT Positive Donors (After screening on JR398070_3rd Week) |
| 398070 | 60 | 0 | 60 | Vaginal Swab Samples from CT/NG Suspected Donors (Screening Collection_3rd Week) |
| 398029 | 6 | 0 | 6 | Vaginal Swabs Samples from CT Positive Donors (After screening on JR398028_2nd Week) |
| 398028 | 60 | 0 | 60 | Vaginal Swab Samples from CT/NG Suspected Donors (Screening Collection_2nd Week) |
| 398001 | 43 | 0 | 43 | Serum and Plasma matched set samples from HCV High-Risk Donors |
| 397998 | 150 | 0 | 150 | Serum Samples from Apparently Healthy Female Donors_MassSpec Ref Range Project RD006866 |
| 397995 | 300 | 0 | 300 | Serum Samples from Apparently Healthy Pregnant Female Donors_MassSpec Ref Range Project RD006866 |
| 397552 | 6200 | 0 | 6200 | Protocol: cX8-MPLX-572 (RD006770)_cobas® BV/CV test for use on the cobas® 5800/6800/8800 Systems: Clinical Performance and Reproducibility |
| 397452 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors |
| 396918 | 16 | 0 | 16 | Vaginal Swabs Samples from CT/NG Positive Donors (After screening on JR396916) |
| 396916 | 60 | 0 | 60 | Vaginal Swab Samples from CT/NG Suspected Donors (Screening Collection) |
| 396305 | 100 | 0 | 100 | Fresh Whole Blood and Plasma Collection from HIV-1 Positive Donors SRF_0003826/SACQ_0003661 |
| 396067 | 100 | 0 | 100 | Prospective vaginal swab Collection from Symptomatic Donors |
| 395758 | 6 | 0 | 6 | Fresh Raw Stool Samples from Confirmed Negative for C. Difficile and Norovirus in Cepheid |
| 395609 | 43 | 0 | 43 | Pre-Selected Anti-HAV Negative Samples in Inventory |
| 394665 | 39 | 0 | 39 | Pre-Selected HBsAg Positive Serum Samples from Inventory |
| 394394 | 30 | 0 | 30 | Pre-Selected Mycoplasma genitalium Positive Urine Samples from Inventory |
| 392764 | 16 | 0 | 16 | Venous Whole Blood collection for an investigational study related to Protocol 259C |
| 392517 | 390 | 0 | 390 | Pre-selected HCV PCR Positive Serum and Plasma Samples from Inventory |
| 392210 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 392167 | 20000 | 0 | 20000 | Customer Samples kept in Biorepository (Markland Hamilton) |
| 391899 | 60 | 0 | 60 | Fresh Whole Blood Collection from HIV-1 Positive Donors (2-3 donors per collection day) - Afternoon collection |
| 391881 | 60 | 0 | 60 | Fresh Whole Blood Collection from HIV-1 Positive Donors (2-3 donors per collection day) - Afternoon collection |
| 391236 | 520 | 0 | 520 | Prospective Serum Sample Collection from Healthy Pediatric Donors |
| 389777 | 50 | 0 | 50 | HPV Genotyping Testing Service on Hologic Panther System |
| 389774 | 50 | 0 | 50 | HPV DNA Testing Service on Hologic Panther System |
| 389554 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 389553 | 10000 | 0 | 10000 | A Multi-Site, Point in Time, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, and/or Blood Samples from Pediatric D/Ps (Donor/Participants). |
| 388482 | 10000 | 0 | 10000 | Pre-selected Samples for Abbott (Generic JR) |
| 388255 | 250 | 0 | 250 | Venous Whole Blood and Capillary whole blood for Clinical Evaluation of the Xpert Hemorrhagic Fever Test_Protocol 259C |
| 387050 | 10 | 0 | 10 | Pre-Selected Zika Positive Plasma Samples from Inventory |
| 387049 | 60 | 0 | 60 | PAS -19SUST046 - Evaluation of BD Vacutainer® PPT™ Plasma Preparation Tube with Hemogard™ Closure for Repeatability and Reproducibility of Molecular Diagnostic Testing using HIV-1 Viral Load (VL) Assay |
| 387036 | 10 | 0 | 10 | Pre-Selected Dengue Positive Plasma Samples from Inventory |
| 387035 | 10 | 0 | 10 | Pre-Selected Chikungunya Positive Plasma Samples from Inventory |
| 386936 | 10 | 0 | 10 | Pre-Selected SARs-CoV-2 Positive Plasma Samples from Inventory |
| 386831 | 60 | 0 | 60 | PAS-18SUST033 - Evaluation of the Clinical Performance of BD Vacutainer® PPT™ Plasma Preparation Tube with Hemogard™ Closure using Molecular Diagnostic Testing Human Immunodeficiency Virus (HIV-1) Viral Load (VL) Assay. |
| 386505 | 250 | 0 | 250 | CT/GC Combo Testing Service on Hologic Panther System |
| 384451 | 100 | 0 | 100 | CT/GC Combo Testing Service on Hologic Panther System |
| 384196 | 1200 | 0 | 1200 | Endocervical Swab Samples from Suspected HPV Donors_SRF_0003813 |
| 383158 | 200 | 0 | 200 | Prospective Rectal Swab Collection from Ct/Ng Symptomatic Donors |
| 382256 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 380133 | 25 | 0 | 25 | Fresh Whole Blood Collection from Healthy Donors |
| 380129 | 25 | 0 | 25 | Fresh Whole Blood Collection from Healthy Donors |
| 379057 | 21 | 0 | 21 | HPV DNA Testing Service on Hologic Panther System |
| 378476 | 5 | 0 | 5 | Pre-Selected Dengue NS1 Positive Samples from Inventory |
| 377709 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 377054 | 700 | 0 | 700 | Serum Samples from Donors with FT4 results from IRL. |
| 376909 | 310 | 0 | 310 | Prospective Serum Collection from Healthy Pediatric Cohorts - Healthy based health check questionnaire - Age:10-20 years old - BMI: 5th percentile- 85th percentile |
| 373958 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens |
| 373935 | 20 | 0 | 20 | Prospective ACD fresh whole blood from healthy donors - In BD #364606 - Non Smokers - Normal Glucose Patients - lean (normal BMI_Healthy Weight) - 60 years and older |
| 373582 | 200 | 0 | 200 | Plasma, Serum, and Saliva samples from donors with fever from Colombia |
| 373511 | 100 | 0 | 100 | HBsAg, HIV-Ag, and HCV-Ag cassette evaluation using fresh whole blood samples and fresh whole blood spiked samples. |
| 373102 | 10000 | 0 | 10000 | A Multi-Site, Point in Time, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, and/or Blood Samples from Pediatric D/Ps (Donor/Participants). |
| 372833 | 150 | 0 | 150 | Prospective collection from Healthy Donors |
| 369311 | 100 | 0 | 100 | HPV Genotyping Testing Service on Hologic Panther System |
| 366644 | 5000 | 9 | 4991 | Refer to Processing Instructions @ Attachment Tab |
| 365916 | 140 | 98 | 42 | Serum Samples from Donors with TT4 results. |
| 362981 | 2 | 2 | 0 | Vaginal Swab Collection from Yeast Infection Symptomatic Female Donors. |
| 362249 | 46 | 46 | 0 | Lyme IgG and Lyme IgM Testing in the Liaison XL |
| 355419 | 1500 | 0 | 1500 | cobas® MPLX Respiratory for use on cobas® 5800/6800/8800 Systems: Reproducibility Study_ cX8-MPLX-584 _ RD006809 |
| 354307 | 80 | 165 | -85 | Clinical Evaluation of the Xpert® Respiratory Panel for Adenovirus Detection, Cepheid 263C1-C3 |
| 349332 | 200 | 45 | 155 | Venous Whole Blood and Capillary whole blood for Pre-Clinical Evaluation of the Xpert Hemorrhagic Fever Test_Protocol 259B2 |
| 349032 | 14000 | 146 | 13854 | Comparator Method Testing Aptima and Alinity m |
| 344846 | 300 | 71 | 229 | Protocol: LIA-RESP-569 (RD006493)_Testing services for archived (frozen) samples received at BCW. |
| 344240 | 60 | 7 | 53 | Nasal Swab Collection from FluA/FluB Positive Donors |
| 342645 | 1000 | 838 | 162 | Protocol: cX8-MPLX-577 (RD006700)_Testing services for archived (frozen) samples received at BCW. |
| 342354 | 60 | 10 | 50 | Prospective Collection for Positive Flu A, Flu B, RSV or Covid Donors from BCW-PR |
| 340975 | 450 | 350 | 100 | Protocol: LIA-RESP-569 Collection & Testing (RD006493) of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections |
| 340639 | 1000 | 565 | 435 | Protocol: COL-RESP-528_Testeng services for samples collected at external facilities |
| 340638 | 1000 | 591 | 409 | Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections - Miami |
| 339042 | 159 | 33 | 126 | HxV-VL Testing in Abbott m2000 |
| 335726 | 100 | 5 | 95 | SARS-CoV-2, Flu A, Flu B, and RSV Positive Nasal, Oropharyngeal, Nasopharyngeal and Blood Collection Protocol |
| 329522 | 4338 | 8647 | -4309 | Disposition of BioRepository Samples -Urine and Plasma Negative samples from Talents |
| 327905 | 50 | 20 | 30 | Serum and Plasma samples from Pregnant donors with a high risk of HSV-2 Infection. |
| 324678 | 32 | 3062 | -3030 | Samples selected from Siemens Biorepository to ship out to indicated locations. |
| 316965 | 100 | 26 | 74 | HxV-VL Testing in Abbott m2000 |
| 293648 | 30 | 13 | 17 | Prospective Collection for subjects with CoV-2, Flu A, Flu B, RSV |
| 292590 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, Vaginal Swab, Rectal Swab, Lesion Swab, Saliva Sample and/or Blood Samples from a positive or suspected positive D/Ps with Monkeypox |
| 283190 | 200 | 113 | 87 | Protocol No. LIA-STI-250 - cobas CT/NG/MG Nucleic acid test for use on the cobas Liat System: Feasibility Performance Evaluation |
| 282610 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Sample Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 266931 | 120 | 17 | 103 | PAS-19SUST053 Testing HBV VL (Abbott & Hologic) |
| 251350 | 100 | 44 | 56 | SARS-CoV-2 Positive Nasal, Oropharyngeal Dry Swab and Raw Saliva Collection Protocol |
| 242206 | 5000 | 27712 | -22712 | COVID-19 Testing |
| 239188 | 500 | 0 | 500 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella |
| 227994 | 130 | 5 | 125 | PAS-19SUST054 - HCV |
| 225611 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 224514 | 600 | 76 | 524 | Initiative to Screen Potential Study Candidates (SUST) |
| 190737 | 5000 | 95 | 4905 | SARS-CoV-2 Survey (PT) |
| 182696 | 1000 | 355 | 645 | Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections |
| 173768 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Saliva, Sputum, Nasal, Pharyngeal, Blood and/or Finger Stick Specimens from SARS-CoV-2 positive subjects |
| 152854 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 151681 | 5000 | 3 | 4997 | Refer to Processing Instructions @ Attachment Tab |
| 149547 | 5000 | 390 | 4610 | Refer to Processing Instructions @ Attachment Tab TESTS TO SELECT PER LOCATION - REFER TO ATTACHMENT TAB |
| 148791 | 5000 | 56 | 4944 | Refer to Processing Instructions @ Attachment Tab |
| 145574 | 5000 | 165 | 4835 | Refer to Processing Instructions @ Attachment Tab |
| 144620 | 5000 | 79 | 4921 | Refer to Processing Instructions @ Attachment Tab |
| 142755 | 5000 | 167 | 4833 | Refer to Processing Instructions @ Attachment Tab |
| 141914 | 1000 | 7 | 993 | HIV Initiative |
| 141493 | 5000 | 75 | 4925 | HCV Viral Load and Genotype Survey (PT) |
| 141491 | 5000 | 30 | 4970 | HBV Viral Load Survey (PT) |
| 141490 | 5000 | 90 | 4910 | HIV Viral Load Survey (PT) |
| 140923 | 5000 | 161 | 4839 | Refer to Processing Instructions @ Attachment Tab |
| 140922 | 5000 | 75 | 4925 | Refer to Processing Instructions @ Attachment Tab |
| 140530 | 5000 | 10 | 4990 | Rubella IgG (AAB - PT) |
| 140528 | 5000 | 6 | 4994 | ToRCH (AAB - PT) |
| 139409 | 5000 | 171 | 4829 | Pregnancy (PT) |
| 137933 | 5000 | 0 | 5000 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon |
| 137683 | 930 | 235 | 695 | Preeclampsia Blood Collection Protocol from Asymptomatic and Symptomatic Populations |
| 129688 | 200 | 163 | 37 | EBV / EBK Samples from National Center of Urology - Tbilisi, Georgia |
| 129538 | 1000 | 309 | 691 | RPR Initiative |
| 124266 | 5000 | 143 | 4857 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cote D'Ivoire |
| 122931 | 5000 | 4092 | 908 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella |
| 122654 | 5000 | 171 | 4829 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Swaziland |
| 120851 | 140 | 26 | 114 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV |
| 109382 | 100 | 32 | 68 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV |
| 109381 | 300 | 6 | 294 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV |
| 108692 | 1000 | 1268 | -268 | HxV Testing Initiative |
| 102419 | 1000 | 681 | 319 | Samples on hold for future shipments to China |
| 98830 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP, Endocervical Swab, Vaginal Swab, Nasal Swab, Pharyngeal Swab, Rectal Swab, Urethral Swab and/or Urine Samples |
| 98084 | 1000 | 576 | 424 | CBC Qualifying Job Request |
| 96278 | 195 | 185 | 10 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella |
| 96055 | 40 | 2275 | -2235 | Hologic Panels for HIV and HCV |
| 94841 | 500 | 1 | 499 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV - LGR |
| 80997 | 5000 | 428 | 4572 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon |
| 78138 | 300 | 140 | 160 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV |
| 78137 | 300 | 414 | -114 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV |
| 74261 | 10000 | 0 | 10000 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella |
| 68258 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 63868 | 1000 | 1585 | -585 | Blinded HIV/HBV/HCV Prospective Blood Collection Protocol from Guinea Bissau |
| 56717 | 20000 | 0 | 20000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP , Endocervical, Vaginal, Nasal and/or Urine Samples |
| 55075 | 10000 | 28 | 9972 | Beta HCG Matched Set Prospective Blood Collection Protocol |
| 54664 | 200 | 148 | 52 | Random Cadaveric Samples |
| 27615 | 15000 | 633 | 14367 | Prospective Blood Collection Protocol in order to Collect Samples from Donor/Participants (D/Ps) in Low Socio-Economic Regions of the World |
| 26761 | 10000 | 482 | 9518 | HIV Positive Time Stability Whole Blood Collection Protocol |
| 10694 | 3000 | 2234 | 766 | HCV Longitudinal Prospective Blood Collection Protocol |
| 10693 | 3000 | 369 | 2631 | HBV Multi-Point Prospective Blood Collection Protocol |
| 8568 | 300 | 1777 | -1477 | Positive Plasma Units from Blood Centers Around the World (HIV, HBsAg & HCV) |
BCW helps clinicians during their research process through collection sites and D/P availability. Our collection sites have been duly inspected and adhere to our Good Manufacturing Practices thus ensuring reliability during the collection process. In addition to this we provide training seminars as part of our Quality Assurance in order to maintain the level of quality that our customers are accustomed to.
You will be invited to participate in research studies for the advancement of diagnostic technologies. Participation in these studies is voluntary. Our D/P's are informed of what the research projects are about and are given an Informed Consent, which evidences their willingness to participate. In order to protect our D/P's we never divulge your identity to the research facilities thus guaranteeing D/P confidentiality.
